SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-024490
Filing Date
2022-05-06
Accepted
2022-05-06 14:50:47
Documents
14
Period of Report
2022-05-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea159542-8k_inmedphar.htm   iXBRL 8-K 36738
2 NEWS RELEASE, DATED MAY 5, 2022 ea159542ex99-1_inmedphar.htm EX-99.1 26798
6 GRAPHIC ex99-1_001.jpg GRAPHIC 5074
  Complete submission text file 0001213900-22-024490.txt   252657

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE inm-20220505.xsd EX-101.SCH 3039
4 XBRL LABEL FILE inm-20220505_lab.xml EX-101.LAB 34476
5 XBRL PRESENTATION FILE inm-20220505_pre.xml EX-101.PRE 22600
8 EXTRACTED XBRL INSTANCE DOCUMENT ea159542-8k_inmedphar_htm.xml XML 3632
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 22900546
SIC: 2834 Pharmaceutical Preparations